Search results
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in IBD (2021) The last guideline on opportunisitic infection in IBD patients was published in 2014. The aims of the new guideline are the update the current and new biological therapies and their impact on opportunistic infections to summarise what to recommend to and ...
- Print
ECCO Guidelines on the Prevention, Diagnosis, and Management...
- Ecco Scientific Workshop Papers
Results of the Eighth Scientific Workshop of ECCO:...
- Other Publications
The number of patients suffering from the two major forms of...
- ECCO Position Statements
ECCO IBD Curriculum. January 2017. Quality of Care Standards...
- ECCO Congress Abstracts
ECCO Congress Abstracts - Published ECCO Guidelines -...
- ECCO Guidelines
ECCO Guidelines - Published ECCO Guidelines - ecco-ibd.eu
- Print
17 mar 2021 · The current document is focused on viral, mycobacterial, bacterial, fungal, and parasitic infections and on vaccination strategies for immunosuppressed IBD patients. The target audience includes IBD specialists, gastroenterologists, surgeons, and paediatricians.
18 gru 2022 · These include the risk of cancers associated with IBD, the risk of cancers from therapies used to treat IBD, and the management of IBD in a patient with active or recent cancer. This guideline was created according to ECCO’s standardised methodology.
Since the initiation of the first project in 2006, the ECCO Guidelines have become standard references for IBD management in Europe and around the world. The guidelines are freely accessible and available for download on the ECCO Website and on JCC Online.
The ECCO e-Guide is a freely-accessible online platform for Healthcare Professionals in IBD, which aims to visualise the ECCO Guidelines as algorithms based primarily on the main UC and CD Guidelines of ECCO.
23 cze 2023 · This is the second European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on extraintestinal manifestations [EIMs] of inflammatory bowel disease [IBD] and anaemia. 1 Up to 50% of patients with IBD will develop at least one EIM, which may impact each body system 2; hence they are a source of considerable morbidity, or even ...
With the new ECCO Guidelines on Therapeutics in CD (published in 2019) and UC (publication expected in 2021), the key policy of ECCO was confirmed - establishing that guidance given by the ECCO e-Guide is based on evidence and validated processes – which are properly referenced.
